Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
0.292
-0.005 (-1.75%)
Nov 4, 2024, 4:00 PM EST - Market closed

Cara Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
1640577651754752
Upgrade
Market Cap Growth
-90.77%-92.99%-11.37%-13.64%0.26%46.64%
Upgrade
Enterprise Value
7-35400462626507
Upgrade
Last Close Price
0.290.7410.7412.1815.1316.11
Upgrade
PE Ratio
--0.34-6.74-6.9885.30-6.46
Upgrade
PS Ratio
1.451.9313.7828.285.5837.82
Upgrade
PB Ratio
1.380.713.632.863.034.03
Upgrade
P/FCF Ratio
-0.17-0.43-7.33-10.83-129.19-6.88
Upgrade
P/OCF Ratio
-0.18-0.44-7.33-10.84-137.41-6.88
Upgrade
EV/Sales Ratio
0.60-1.699.5520.054.6425.52
Upgrade
EV/EBITDA Ratio
0.100.29-4.58-5.20111.96-4.55
Upgrade
EV/EBIT Ratio
0.100.29-4.57-5.18116.31-4.54
Upgrade
EV/FCF Ratio
0.120.38-5.08-7.68-107.32-4.65
Upgrade
Debt / Equity Ratio
4.070.760.010.020.020.02
Upgrade
Debt / EBITDA Ratio
----0.79-
Upgrade
Debt / FCF Ratio
-0.57-0.46-0.02-0.06-0.90-0.04
Upgrade
Asset Turnover
0.110.140.200.090.540.09
Upgrade
Inventory Turnover
35.0943.6439.46---
Upgrade
Quick Ratio
4.204.096.399.559.903.66
Upgrade
Current Ratio
4.594.547.209.8410.553.86
Upgrade
Return on Equity (ROE)
-184.32%-109.80%-44.25%-37.12%3.86%-66.41%
Upgrade
Return on Assets (ROA)
-63.43%-49.30%-25.49%-21.49%1.34%-32.94%
Upgrade
Return on Capital (ROIC)
-77.80%-58.20%-27.92%-22.94%1.51%-43.00%
Upgrade
Earnings Yield
-694.07%-292.78%-14.81%-13.58%1.12%-14.15%
Upgrade
FCF Yield
-520.65%-233.34%-13.65%-9.23%-0.77%-14.53%
Upgrade
Buyback Yield / Dilution
-1.24%-0.92%-5.79%-5.85%-12.29%-18.88%
Upgrade
Total Shareholder Return
-1.24%-0.92%-5.79%-5.85%-12.29%-18.88%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.